Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Scalp basal cell carcinoma in Asians is different from facial basal cell carcinoma, with unique features like being more common in younger people and having larger tumors.

Scalp basal cell carcinoma may be more aggressive and harder to treat than other types, requiring special attention and further research.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Basal cell carcinoma mostly starts from cells in the upper skin layers, not hair follicle stem cells.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

Basal cell carcinomas have much higher levels of Vitamin D3 receptors compared to healthy skin.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

The patient was diagnosed with oral lichen sclerosus and needs long-term monitoring.

Understanding molecular processes in skin development is key to creating targeted treatments for skin disorders.

Skin and hair renewal is maintained by both fast and slow cycling stem cells, with hair regrowth primarily driven by specific stem cells in the hair follicle bulge. These cells can also help heal wounds and potentially treat hair loss.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

Some skin tumors from hair follicles and glands can be linked to genetic syndromes and may be benign or malignant.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

SOX9 helps determine stem cell roles by interacting with DNA and proteins that control gene activity.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Apoptosis is crucial for healthy skin and treating skin diseases.